- 2.4Impact Factor
- 4.1CiteScore
- 18 daysTime to First Decision
Dyslipidemia, Obesity and Metabolic Dysfunction-Associated Fatty Liver Disease: From Roots to Management
This special issue belongs to the section “Endocrinology“.
Special Issue Information
Dear Colleagues,
Patients with metabolic dysfunction-associated fatty liver disease (MAFLD), often considered the hepatic manifestation of metabolic syndrome (MetS), represent a population frequently suffering from atherogenic dyslipidemia and posing a significantly increased cardiovascular risk. Since dyslipidemia, obesity/MetS and MAFLD share etiopathogenesis roots and are all major drivers of atherosclerotic cardiovascular disease, impaired quality of life and reduced life span, their early detection and comprehensive multidisciplinary management are warranted.
Considering their constantly growing prevalence and associated global public health concerns, we are collating this Special Issue titled “Dyslipidemia, Obesity and Metabolic Dysfunction-Associated Fatty Liver Disease: From Roots to Management”.
For this Special Issue, we aim to publish outstanding contributions in the key fields covered by the journal, which will make a great contribution to the community. Thus, we believe that Medicina is an excellent platform to support such an overview on the current evidence and insights regarding dyslipidemia, obesity/metabolic syndrome and MAFLD.
We hope that our Special Issue will draw the attention of the readers, scientists and clinicians in general.
Dr. Andrej Belančić
Prof. Dr. Željko Krznarić
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adipose tissue
- dyslipidemia
- metabolic dysfunction-associated fatty liver disease
- metabolic syndrome
- obesity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

